# Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee Surgery

> **NCT00333567** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 110 (—)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Lumiracoxib

## Key facts

- **NCT ID:** NCT00333567
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 110 (—)
- **Last updated:** 2007-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00333567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00333567, "Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee Surgery". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00333567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*